Buchumschlag

Development and validation of an eating behavior patient‐reported outcome measure in people living with obesity or overweight

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Donald M. Bushnell, Shirley Fung, Meryl Brod, Carl A. Roberts, Carel W. Le Roux, Oren Steen, Kathryn J. Lucas, Anita M. Hennige, Anastasia Uster
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Obesity
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Subgroup analysis by sex and baseline BMI in people with a BMI ≥27 kg/m 2 in the phase 2 trial of survodutide, a glucagon/ GLP ‐1 receptor dual agonist
von: Carel W. le Roux, et al.
Veröffentlicht: (2025)

Survodutide, a glucagon receptor/glucagon‐like peptide‐1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo‐controlled, dose‐finding, phase 2 trial
von: Carel W. le Roux, et al.
Veröffentlicht: (2024)

Anti‐obesity treatment preferences of healthcare providers and people living with obesity: A survey‐based study
von: Carel W. Le Roux, et al.
Veröffentlicht: (2024)

Potential pathways to the onset and development of eating disorders in people with overweight and obesity: A scoping review
von: Rabia Khalid, et al.
Veröffentlicht: (2024)

The real‐life experiences of people living with overweight and obesity: A psychosocial perspective
von: Stuart W. Flint, et al.
Veröffentlicht: (2025)

A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low‐dose liraglutide in otherwise healthy men with overweight or obesity
von: Nadine Beetz, et al.
Veröffentlicht: (2024)

Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world ( STEER )
von: Lauren Wilson, et al.
Veröffentlicht: (2026)

Barriers and enablers to effective weight management for people living with overweight and obesity: A rapid scoping review
von: Alemayehu Mekonnen, et al.
Veröffentlicht: (2024)

Why do patients with obesity discontinue glucagon‐like peptide 1 analogues?
von: Faisal I. Almohaileb, et al.
Veröffentlicht: (2025)

Rapid response to behavioral/pharmacological obesity treatments for binge‐eating disorder predicts better clinical outcomes
von: Janet A. Lydecker, et al.
Veröffentlicht: (2025)

Impact of COVID‐19 pandemic on sleep parameters and characteristics in individuals living with overweight and obesity
von: Stephen A. Glazer, et al.
Veröffentlicht: (2024)

The impact of behavioral weight management interventions on eating behavior traits in children with overweight or obesity: Systematic review and meta‐analysis
von: Patricia Eustachio Colombo, et al.
Veröffentlicht: (2024)

Association between patient‐reported eating behaviours and weight change: Secondary analyses of a randomized, double‐blind trial comparing retatrutide and placebo in people with obesity or overweight
von: Chisom Kanu, et al.
Veröffentlicht: (2025)

The impact of overweight and obesity on health outcomes in the United States from 1990 to 2021
von: Omar Al Ta'ani, et al.
Veröffentlicht: (2024)

The impact of behavioral weight management interventions on eating behavior traits in adults with overweight or obesity: A systematic review and meta‐analysis
von: Laura Kudlek, et al.
Veröffentlicht: (2024)

Exploring potential reach and representativeness of a self‐weighing weight gain prevention intervention in adults with overweight and obesity
von: Kellie B. Scotti, et al.
Veröffentlicht: (2024)

The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity
von: Iskandar Idris, et al.
Veröffentlicht: (2025)

Real‐world data of a digitally enabled, time‐restricted eating weight management program in public sector workers living with overweight and obesity in the United Kingdom: A service evaluation of the Roczen program
von: Adrian Brown, et al.
Veröffentlicht: (2024)

Modeling potential cost‐effectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity
von: Meredith M. Hoog, et al.
Veröffentlicht: (2025)

Weight loss interventions and obesity‐associated cancers in people with type 2 diabetes and overweight/obesity: A real‐world observational study
von: Testimony Ipaye, et al.
Veröffentlicht: (2025)

Mindful eating and its relationship with body mass index, binge eating, anxiety and negative affect
von: Sheila Pintado-Cucarella
Veröffentlicht: (2016)

Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes
von: Ebaa Al‐Ozairi, et al.
Veröffentlicht: (2024)

Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials
von: Kathryn Giblin, et al.
Veröffentlicht: (2025)

Musculoskeletal characteristics in older adults with overweight or obesity: INVEST in Bone Health trial baseline analysis
von: S. Delanie Lynch, et al.
Veröffentlicht: (2025)

The double burden: Navigating type 1 diabetes and obesity
von: Nele Steenackers, et al.
Veröffentlicht: (2024)

Myocardial mechano‐energetic efficiency is not impaired in patients with metabolically healthy overweight and obesity
von: Chiara Maria Assunta Cefalo, et al.
Veröffentlicht: (2024)

Maternal folic acid supplementation during pregnancy in association with childhood overweight or obesity
von: Chi‐Yen Hung, et al.
Veröffentlicht: (2024)

What are Internal medicine residents' attitudes toward obesity as a disease, people living with obesity, and obesity treatment?
von: Kacey Chae, et al.
Veröffentlicht: (2024)

Efficacy of an mHealth‐delivered behavioral intervention on weight loss and cardiometabolic risk in African American postpartum people with overweight or obesity: the SnapBack randomized controlled trial
von: Sharon J. Herring, et al.
Veröffentlicht: (2024)

Racial disparities in gestational weight gain and adverse pregnancy outcomes among Black and White pregnant people with obesity
von: Chelsea L. Kracht, et al.
Veröffentlicht: (2024)

Lifestyle behavioral weight‐loss treatment for binge‐eating disorder in patients with obesity: where's the harm?
von: Sydney Yurkow, et al.
Veröffentlicht: (2025)

The prognostic role of food addiction for weight loss treatment outcomes in individuals with overweight and obesity: A systematic review and meta‐analysis
von: Georg Halbeisen, et al.
Veröffentlicht: (2024)

β‐alanine supplementation in adults with overweight and obesity: a randomized controlled feasibility trial
von: Joseph J. Matthews, et al.
Veröffentlicht: (2025)

Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study
von: Jamy D. Ard, et al.
Veröffentlicht: (2025)

Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™‐1 and ‐2)
von: Sean Wharton, et al.
Veröffentlicht: (2024)

Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparison
von: Emily R. Hankosky, et al.
Veröffentlicht: (2025)

Association of overweight/obesity and overweight/obesity‐related metabolic dysfunction‐associated steatotic liver disease in young adults with coronary artery calcification later in life
von: Jia‐Jie Wang, et al.
Veröffentlicht: (2024)

What is known about the use of weight loss medication in women with overweight/obesity on fertility and reproductive health outcomes? A scoping review
von: Kate Maslin, et al.
Veröffentlicht: (2024)

Mid‐term outcomes of valve replacement surgery with or without coronary artery bypass grafting in patients with overweight and obesity: A cohort study
von: Nadia Rajablou, et al.
Veröffentlicht: (2024)

Prevalence of overweight and obesity in incarcerated individuals in developed and developing countries: A systematic review and meta‐analysis
von: Leonida Nyarwaba Mosomi, et al.
Veröffentlicht: (2025)